Similar Items: Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis
- Secondary Syphilis With Concomitant Bullous Pemphigoid: A Case Report
- Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab
- Mendelian Randomization and Experimental Validation Identify Key Immune Signatures in Bullous Pemphigoid
- Successful Treatment of IL‐23 Inhibitor–Refractory Nail Psoriasis With Deucravacitinib: A Case Report
- Off-Label Uses of Deucravacitinib for Inflammatory Skin Conditions: Cases and Literature Review
- Mucous membrane pemphigoid of the larynx: A rare threat to vocal and airway integrity